PROTEUSONE PROTEUS 235

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-04-07 for PROTEUSONE PROTEUS 235 manufactured by Ion Beam Applications.

Event Text Entries

[72667301] Evaluation summary: by using the following workflow, iba has been able to reproduce the issue: 1. Irradiation abort occurs, 2. User inputs delivered dose manually in the oncology information system and selects the aborted beam, 3. User selects the delivered dose from the oncology information system in the "partial report" dialog box in the "beam selection" screen, 4. User goes to "irradiation preparation" screen and then goes back to "beam selection" screen, 5. User cancels and reselects the aborted beam, 6. The "next" button is enabled in the "beam selection" screen and user is able to start irradiation without having to select the delivered dose in the "partial report" dialog box.. In step 6, the correct behavior of the system should be: the "next" button is disabled in the "beam selection" screen and user has to select the delivered dose in "partial report" dialog box.. Note that the "partial report" dialog box is a popup window which is shown in the center of "beam selection" screen when clicking on "partial" button in the "beam selection" screen.
Patient Sequence No: 1, Text Type: N, H10


[72667302] Iba learned from a user that while a patient was being treated in pencil beam scanning treatment mode, irradiation was stopped and then the user was able to restart irradiation without having to select the correct partial irradiation data. The customer informed iba that the patient impacted by this malfunction received an over-dose of 38 mu (monitor units) for one fraction of his treatment. The over-dose due to that malfunction was +1. 8% of that fraction (38 mu/2068 mu). This represents about +0. 07% of total prescribed dose (25 fractions of treatment). There was no significant impact on patient treatment. Nevertheless, if the malfunction were to recur at the end of the irradiation, the whole dose of a fraction could be delivered twice, representing a potential over-dose of 1gy to 4gy.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3000256071-2017-00001
MDR Report Key6471364
Date Received2017-04-07
Date of Report2017-02-17
Date of Event2017-02-17
Date Mfgr Received2017-02-17
Device Manufacturer Date2014-09-02
Date Added to Maude2017-04-07
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPHYSICIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. SYLVIANE BERGER
Manufacturer StreetCHEMIN DU CYCLOTRON 3
Manufacturer CityLOUVAIN-LA-NEUVE, 1348
Manufacturer CountryBE
Manufacturer Postal1348
Manufacturer Phone10 203787
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NamePROTEUSONE
Generic NamePROTON THERAPY SYSTEM
Product CodeLHN
Date Received2017-04-07
Model NumberPROTEUS 235
Catalog NumberPROTEUS 235
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerION BEAM APPLICATIONS
Manufacturer AddressCHEMIN DU CYCLOTRON 3 LOUVAIN-LA-NEUVE, 1348 BE 1348


Patients

Patient NumberTreatmentOutcomeDate
10 2017-04-07

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.